Literature DB >> 15994927

Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2.

Jihyung Choi1, Kyusam Choi, Etty N Benveniste, Seung Bae Rho, Young-Sook Hong, Je-Ho Lee, Jhingook Kim, Kyoungsook Park.   

Abstract

Bcl-2 is involved in the progression of human malignancies, but the precise role and mechanism of Bcl-2 for tumor invasion and metastasis remains unclear. In this study, we have investigated the role and mechanism of Bcl-2 on tumor cell invasion and metastasis by using Bcl-2 overexpressing non-small cell lung cancer cells. Matrix metalloproteinases (MMPs) are important proteins involved in the processes of tumor invasion and metastasis. In vitro Matrigel invasion assays showed that Bcl-2 overexpression increased tumor cell invasion by 15-fold. Moreover, Bcl-2 overexpression enhanced in vivo lung metastasis by 4-fold. Consistent with its effect on invasion and metastasis, Bcl-2 overexpression induced not only MMP-2 mRNA and its protein expression, but this also activated the pro-MMP-2 protein to its active form. To explore the induction mechanism of MMP-2 by Bcl-2, we investigated the effects of Bcl-2 overexpression on MMP-2 transcriptional regulation. Nuclear run-on assays showed a 6-fold increase in the transcription rate of MMP-2 mRNA in the Bcl-2 transfectants (H157/Bcl-2) compared with that of the H157/vector control cells (H157/C). Overexpression of Bcl-2 induced the nuclear transcription factor activator protein 1 family, including the c-Jun, JunD, c-Fos, FosB, and Fra-1 proteins. Reporter assays combined with deletion mutagenesis analysis and gel shift assays showed the involvement of activator protein 1 in the activation of MMP-2 promoter activity by Bcl-2. Taken together, we have shown that Bcl-2 promotes tumor invasion and lung metastasis by inducing MMP-2 gene expression through the combined action of transcriptional and posttranslational mechanisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15994927     DOI: 10.1158/0008-5472.CAN-04-4570

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  42 in total

Review 1.  Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted.

Authors:  Kendra J Greenlee; Zena Werb; Farrah Kheradmand
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

Review 2.  Causes of genome instability: the effect of low dose chemical exposures in modern society.

Authors:  Sabine A S Langie; Gudrun Koppen; Daniel Desaulniers; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Amaya Azqueta; William H Bisson; Dustin G Brown; Gunnar Brunborg; Amelia K Charles; Tao Chen; Annamaria Colacci; Firouz Darroudi; Stefano Forte; Laetitia Gonzalez; Roslida A Hamid; Lisbeth E Knudsen; Luc Leyns; Adela Lopez de Cerain Salsamendi; Lorenzo Memeo; Chiara Mondello; Carmel Mothersill; Ann-Karin Olsen; Sofia Pavanello; Jayadev Raju; Emilio Rojas; Rabindra Roy; Elizabeth P Ryan; Patricia Ostrosky-Wegman; Hosni K Salem; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Frederik J Van Schooten; Mahara Valverde; Jordan Woodrick; Luoping Zhang; Nik van Larebeke; Micheline Kirsch-Volders; Andrew R Collins
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

Review 3.  Non-apoptotic functions of BCL-2 family proteins.

Authors:  Atan Gross; Samuel G Katz
Journal:  Cell Death Differ       Date:  2017-02-24       Impact factor: 15.828

4.  Study on the molecular regulatory mechanism of MicroRNA-195 in the invasion and metastasis of colorectal carcinoma.

Authors:  Bin Yang; Zhigang Tan; Yan Song
Journal:  Int J Clin Exp Med       Date:  2015-03-15

5.  AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration.

Authors:  Kyoungsook Park; Yong Jin Chung; Hyekyung So; Kwangsoo Kim; Junsoo Park; Mijoung Oh; Minwha Jo; Kyusam Choi; Eun-Ju Lee; Yoon-La Choi; Sang Yong Song; Duk-Soo Bae; Byoung-Gie Kim; Je-Ho Lee
Journal:  Exp Mol Med       Date:  2011-02-28       Impact factor: 8.718

6.  A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer.

Authors:  Maria Q Baggstrom; Yingwei Qi; Marianna Koczywas; Athanassios Argiris; Elizabeth A Johnson; Michael J Millward; Sara C Murphy; Charles Erlichman; Charles M Rudin; Ramaswamy Govindan
Journal:  J Thorac Oncol       Date:  2011-10       Impact factor: 15.609

7.  Src and epidermal growth factor receptor mediate the pro-invasive activity of Bcl-w.

Authors:  Eun Mi Kim; Jong Kuk Park; Sang-Gu Hwang; Hong-Duck Um
Journal:  Tumour Biol       Date:  2015-08-20

8.  High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology.

Authors:  Valsamo K Anagnostou; Frank J Lowery; Vassiliki Zolota; Vassiliki Tzelepi; Arun Gopinath; Camil Liceaga; Nikolaos Panagopoulos; Konstantina Frangia; Lynn Tanoue; Daniel Boffa; Scott Gettinger; Frank Detterbeck; Robert J Homer; Dimitrios Dougenis; David L Rimm; Konstantinos N Syrigos
Journal:  BMC Cancer       Date:  2010-05-09       Impact factor: 4.430

9.  Targeting the apoptotic pathway with BCL-2 inhibitors sensitizes primary chronic lymphocytic leukemia cells to vesicular stomatitis virus-induced oncolysis.

Authors:  Vanessa Fonseca Tumilasci; Stephanie Olière; Thi Lien-Ahn Nguyên; April Shamy; John Bell; John Hiscott
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

10.  A computational approach to resolve cell level contributions to early glandular epithelial cancer progression.

Authors:  Sean H J Kim; Jayanta Debnath; Keith Mostov; Sunwoo Park; C Anthony Hunt
Journal:  BMC Syst Biol       Date:  2009-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.